Piracetam

Generic Name
Piracetam
Brand Names
-
Drug Type
Small Molecule
Chemical Formula
C6H10N2O2
CAS Number
7491-74-9
Unique Ingredient Identifier
ZH516LNZ10
Background

Piracetam is a nootropic drug in the racetams group, with chemical name 2-oxo-1-pyrrolidine acetamide. It shares the same 2-oxo-pyrrolidone base structure with pyroglutamic acid and is a cyclic derivative of the neurotransmitter γ-aminobutyric acid (GABA). However its mechanism of action differ from that of endogenous GABA. Piracetam has neuroprotective and ...

Indication

Indicated in adult patients suffering from myoclonus of cortical origin, irrespective of aetiology, and should be used in combination with other anti-myoclonic therapies .

Associated Conditions
Alcohol Dependency, Alcohol Withdrawal Syndrome, Cognitive Deficits caused by Injuries, Craniocerebral, Cognitive Dysfunctions, Cognitive Impairment (CI), Comatose caused by Blood Vessel (Vascular) Dysfunction, Comatose caused by CNS Toxicity, Comatose caused by Traumas, Learning Disorders, Myoclonus, Sickle Cell Disease (SCD), Giddiness caused by Injuries, Craniocerebral
Associated Therapies
-
Clinical Trials
Related News

The Effect of Piracetam on Diabetic Peripheral Neuropathy Patients

Phase 4
Not yet recruiting
Conditions
Diabetic Peripheral Neuropathy
Interventions
Drug: Placebo
Drug: Piracetam
First Posted Date
2024-06-28
Last Posted Date
2024-10-09
Lead Sponsor
Ain Shams University
Target Recruit Count
60
Registration Number
NCT06479629

Subtherapeutic Dose of Piracetam as a Therapy Adherence Marker

Phase 4
Not yet recruiting
Conditions
Drug Adherence Marker
Interventions
Drug: Piracetam
First Posted Date
2023-06-26
Last Posted Date
2023-06-26
Lead Sponsor
The Netherlands Cancer Institute
Target Recruit Count
10
Registration Number
NCT05918341

Pharmacovigilance in Gerontopsychiatric Patients

Phase 3
Terminated
Conditions
Dementia
Depression
Schizophrenia
Psychosomatic Disorders
Anxiety Disorders
Interventions
Drug: Phenobarbital
Drug: Phenytoin
Drug: Carbamazepine
Drug: Oxcarbazepine
Drug: Valproic Acid
Drug: Lamotrigine
Drug: Topiramate
Drug: Gabapentin
Drug: Levetiracetam
Drug: Pregabalin
Drug: Lacosamide
Drug: Clonazepam
Drug: Biperiden
Drug: Levomepromazine
Drug: Fluphenazine
Drug: Perphenazine
Drug: Perazine
Drug: Thioridazine
Drug: Haloperidol
Drug: Melperone
Drug: Pipamperone
Drug: Bromperidol
Drug: Benperidol
Drug: Sertindole
Drug: Ziprasidone
Drug: Flupentixol
Drug: Chlorprothixene
Drug: Zuclopenthixol
Drug: Fluspirilene
Drug: Pimozide
Drug: Clozapine
Drug: Olanzapine
Drug: Quetiapine
Drug: Sulpiride
Drug: Tiapride
Drug: Amisulpride
Drug: Prothipendyl
Drug: Risperidone
Drug: Aripiprazole
Drug: Paliperidone
Drug: Diazepam
Drug: Oxazepam
Drug: Lorazepam
Drug: Bromazepam
Drug: Clobazam
Drug: Alprazolam
Drug: Hydroxyzine
Drug: Buspirone
Drug: Chloral Hydrate
Drug: Flurazepam
Drug: Nitrazepam
Drug: Triazolam
Drug: Lormetazepam
Drug: Temazepam
Drug: Midazolam
Drug: Brotizolam
Drug: Zopiclone
Drug: Zolpidem
Drug: Zaleplon
Drug: Melatonin
Drug: Clomethiazole
Drug: Diphenhydramine
Drug: Promethazine
Drug: Imipramine
Drug: Clomipramine
Drug: Opipramol
Drug: Trimipramine
Drug: Amitriptyline
Drug: Nortriptyline
Drug: Doxepin
Drug: Maprotiline
Drug: Amitriptyline oxide
Drug: Fluoxetine
Drug: Citalopram
Drug: Paroxetine
Drug: Sertraline
Drug: Fluvoxamine
Drug: Escitalopram
Drug: Tranylcypromine
Drug: Moclobemide
Drug: Mianserin
Drug: Trazodone
Drug: Mirtazapine
Drug: Bupropion
Drug: Venlafaxine
Drug: Reboxetine
Drug: Duloxetine
Drug: Agomelatine
Drug: Pyritinol
Drug: Piracetam
Drug: Donepezil
Drug: Rivastigmine
Drug: Galantamine
Drug: Memantine
Drug: Nicergoline
Drug: Acamprosate
Drug: Lithium
First Posted Date
2015-03-02
Last Posted Date
2018-02-28
Lead Sponsor
Hannover Medical School
Target Recruit Count
407
Registration Number
NCT02374567
Locations
🇩🇪

Bezirkskrankenhaus Augsburg, Augsburg, Germany

🇩🇪

Krankenhaus Hedwigshöhe, Berlin, Germany

🇩🇪

Hannover Medical School, Hannover, Germany

and more 2 locations

A Study to Evaluate the Efficacy and Safety of Piracetam on Aphasia After Acute Ischemic Cerebral Artery Stroke

First Posted Date
2013-06-21
Last Posted Date
2013-08-30
Lead Sponsor
UCB S.A. - Pharma Sector
Target Recruit Count
571
Registration Number
NCT01883011
Locations
🇧🇪

103, Antwerpen, Belgium

🇬🇷

252, Athens, Greece

🇦🇹

003, Linz, Austria

and more 41 locations

Efficacy and Safety of Piracetam Taken for 12 Months in Subjects Suffering From Mild Cognitive Impairment (MCI)

Not Applicable
Completed
Conditions
Memory Disorders
First Posted Date
2007-12-04
Last Posted Date
2013-12-16
Lead Sponsor
UCB Pharma
Target Recruit Count
676
Registration Number
NCT00567060

Piracetam for Treatment Tardive Dyskinesia

Phase 3
Completed
Conditions
Tardive Dyskinesia
First Posted Date
2005-09-19
Last Posted Date
2009-11-25
Lead Sponsor
Beersheva Mental Health Center
Target Recruit Count
40
Registration Number
NCT00190008
Locations
🇮🇱

Beersheva Mental Health Center, Beersheva, Israel

Piracetam for Treatment of Cocaine Addiction - 3

Phase 1
Completed
Conditions
Cocaine-Related Disorders
First Posted Date
1999-09-21
Last Posted Date
2015-10-06
Lead Sponsor
University of Pennsylvania
Registration Number
NCT00000198
Locations
🇺🇸

University of Pennsylvania, Philadelphia, Pennsylvania, United States

Piracetam for Treatment of Cocaine Addiction, Phase II - 4

Phase 1
Withdrawn
Conditions
Cocaine-Related Disorders
First Posted Date
1999-09-21
Last Posted Date
2017-03-30
Lead Sponsor
University of Pennsylvania
Registration Number
NCT00000199
Locations
🇺🇸

University of Pennsylvania, Philadelphia, Pennsylvania, United States

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy